Zumiez Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Zumiez Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Revenue	836	927	979	1,034	991	1,184	958	875	889	929
Cost of revenue	561	618	643	668	641	727	634	595	586	597
Gross profit	275	310	336	367	350	457	325	281	303	333
Selling, general and administrative	235	261	275	281	253	299	294	346	301	315
Operating income	39.7	48.8	61.1	85.8	96.9	158	31.1	-64.8	1.95	17
Other non-operating income	0.45	-0.85	-0.44	1.53	2	-0.89	-0.56	-0.61	-2.08	2.35
Pre-tax income	40.2	48.4	62.3	91	102	161	32.5	-61.9	4.08	24.1
Income tax	14.3	21.6	17.1	24.1	26.2	41.2	11.4	0.73	5.79	10.7
Net income	25.9	26.8	45.2	66.9	76.2	119	21	-62.6	-1.71	13.4
EBITDA	67.7	76	88.4	111	121	181	52.7	-42	24.1	38.2
EPS, basic	1.05	1.09	1.81	2.65	3.06	4.93	1.10	-3.25	-0.09	0.80
EPS, diluted	1.04	1.08	1.79	2.62	3.00	4.85	1.08	-3.25	-0.09	0.78
Shares, basic (weighted)	24.7	24.7	24.9	25.2	24.9	24.2	19.2	19.3	18.9	16.8
Shares, diluted (weighted)	24.9	24.9	25.2	25.5	25.4	24.6	19.4	19.3	18.9	17.2

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Cash and equivalents	20.2	24	52.4	52.4	73.6	117	81.5	88.9	113	128
Short-term investments					302	177	92	82.7	34.9	32.8
Receivables	7.67	9.74	10.8	10.8	9.75	7.96	7.84	6.53	6.28	5.47
Inventory	107	126	129	135	134	129	135	129	147	147
Other current assets	13.1	14.4	14.8	9.46	8.82	10	11.3	12.4	15.4	14.4
Total current assets	211	279	327	413	535	448	340	327	322	336
Property, plant and equipment	130	129	121	113	98.4	91.5	93.7	90.5	80.2	72.8
Lease right-of-use assets				302	267	230	222	197	183	186
Goodwill	56	62.9	58.8	57.1	61.5	57.6	56.6	15.4	15.3	15.5
Intangible assets	14.6	16.7	15.3	14.6	16	14.7	14.4	14.2	13.6	15.5
Other non-current assets	8.02	7.71	7.18	8.87	10.2	11.8	12.5	12.2	11.6	12.4
Total assets	427	500	534	914	998	862	748	664	635	644
Accounts payable	25.5	37.9	35.3	47.8	69.8	55.6	40.4	38.9	49.4	49.2
Accrued liabilities	4.19	5.5	5.63	4.89	6.72	6.48	6.5	7.1	5.94	5.57
Deferred revenue	4.9	2.57	2.17	0.73	0.9	1.05	1.23	1.11	1.22	1.02
Short-term debt		0.94
Total current liabilities	73.6	99.2	93.1	160	195	184	146	144	156	168
Lease liabilities				285	246	204	189	160	144	145
Other non-current liabilities	4.97	5.07	3.55	3.75	4.19	4.95	5.93	7.05	6.58	7.05
Total liabilities	120	144	134	448	446	394	341	311	306	320
Paid-in capital	141	147	153	161	172	181	188	196	204	212
Retained earnings	183	209	257	317	380	301	239	176	149	124
Other comprehensive income	-16.5	0.04	-9.22	-12.6	0.94	-13.5	-19.8	-19	-23.8	-11.4
Shareholders' equity	307	356	400	466	553	468	407	353	329	324
Total equity	307	356	400	466	553	468	407	353	329	324
Total liabilities and equity	427	500	534	914	998	862	748	664	635	644
Shares outstanding	24.9	25.2	25.5	25.8	25.6	21.2	19.5	19.8	19.2	17

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Net income	25.9	26.8	45.2	66.9	76.2	119	21	-62.6	-1.71	13.4
Depreciation and amortization	27.9	27.3	27.3	25.4	24.1	22.9	21.6	22.8	22.2	21.1
Stock-based compensation	4.58	5.03	5.87	6.38	6.45	6.82	6.99	7.02	6.83	7.27
Deferred income tax	-2.56	3.28	-1.81	0.9	-3.89	2.37	2.49	-1.05	-0.61	2.61
Change in receivables	0.41	-3.22	-2	3.4	0.93	2.88	-1.72	6.86	1.53	2.25
Change in inventory	-7.98	-14.8	-6.22	-6.83	3.95	2.59	-5.28	5.81	-21.7	5.09
Cash from operations	48.5	65.5	65.4	106	138	135	-0.38	14.8	20.7	53.5
Capital expenditures	-20.4	-24.1	-21	-18.8	-9.06	-15.7	-25.6	-20.4	-15	-11.1
Acquisitions	-5.4
Purchases of investments	-86.8	-129	-149	-237	-223	-160	-1.91	-38.3	-2.98	-23.1
Sales and maturities of investments	61.1	89.1	133	153	121	278	81.8	50.2	50.6	27.8
Cash from investing	-51.5	-64	-36.4	-103	-111	102	54.2	-8.55	32.6	-6.39
Debt issued	23.1
Debt repaid	-22.4
Share buybacks	-21.6				-13.4	-194	-87.9		-25.2	-38.3
Cash from financing	-20.1	1.27	0.12	2.01	-9.69	-191	-87.3	0.7	-24.6	-37.3
Exchange rate effect	0.22	0.98	-0.66	-0.43	3.52	-1.82	-2.17	-1.08	-1.46	2.85
Net change in cash	-22.9	3.8	28.5	4.72	21.7	43.4	-35.6	5.83	27.2	12.6
Free cash flow	28.1	41.5	44.4	87.3	129	119	-26	-5.6	5.7	42.4
Income taxes paid	20.5	14.9	18.3	24.1	27.6	42.8	11.3	2.07	2.1	5.88

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $13.31 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.1%	Gross profit / revenue.
Operating margin	2.2%	Operating income / revenue.
EBITDA margin	4.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.5%	Pre-tax income / revenue.
Net margin	1.4%	Net income / revenue.
FCF margin	2.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.8%	Cash from operations / revenue.
Effective tax rate	44.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.0%	Net income / average total assets.
Return on invested capital (ROIC)	4.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	33.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.1%	Capital expenditures / revenue.
D&A / revenue	2.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	9.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	773.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-18.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-29.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	58.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-10.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-20.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-14.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-29.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	-10.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-23.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	158.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-17.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	644.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-20.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-1.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-7.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-10.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-8.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-8.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-7.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.71x	Current assets / current liabilities.
Quick ratio	0.71x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.56x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	55.5%	Total liabilities / total assets.
Working capital	$123.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	4.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$248.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.49x	Revenue / average total assets.
Fixed asset turnover	13.7x	Revenue / average property, plant and equipment.
Inventory turnover	3.79x	Cost of revenue / average inventory.
Days inventory	96 days	365 x average inventory / cost of revenue.
Receivables turnover	37.0x	Revenue / average receivables.
Days sales outstanding	10 days	365 x average receivables / revenue.
Days payables	42 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	64 days	Days inventory + days sales outstanding - days payables.
FCF conversion	197.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	29.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.81	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$59.38	Revenue / diluted weighted shares.
FCF per share	$1.60	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.27	Cash from operations / diluted weighted shares.
Book value per share	$17.60	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$15.67	Tangible book value / shares outstanding.
Cash per share	$6.14	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	137.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$224.6M	Share price x shares outstanding.
Enterprise value	$127.3M	Market cap + total debt - cash - short-term investments.
P/E	17.7x	Market cap / net income. Only when net income is positive.
P/S	0.24x	Market cap / revenue.
P/B	0.80x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.90x	Market cap / tangible book value, when positive.
P/FCF	8.96x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.29x	Market cap / cash from operations, when positive.
EV/Sales	0.14x	Enterprise value / revenue.
EV/EBIT	6.27x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.16x	Enterprise value / EBITDA, when both are positive.
EV/FCF	5.08x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.2%	Free cash flow / market cap.
Earnings yield	5.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	15.4%	(Dividends paid + share buybacks) / market cap.

What was Zumiez Inc's revenue in fiscal 2026?

Zumiez Inc reported revenue of $929.1M for fiscal 2026, 4.5% higher than the year before.

Was Zumiez Inc profitable in fiscal 2026?

Yes. Net income was $13.4M, a net margin of 1.4%.

How much free cash flow did Zumiez Inc generate in fiscal 2026?

Cash from operations of $53.5M minus capital expenditures of $11.1M left free cash flow of $42.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Zumiez Inc